BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34865946)

  • 1. Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study.
    Slater O; Gains JE; Kelsey AM; De Corti F; Zanetti I; Coppadoro B; Jorgensen M; Gallego S; Orbach DH; Glosli H; Cesen M; Gaze MN; Smeulders N; Ferrari A; Jenney M; Minard-Colin V; Bisogno G; Merks JHM;
    Eur J Cancer; 2022 Jan; 160():206-214. PubMed ID: 34865946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
    Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
    Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
    Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
    Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
    Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
    Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
    Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
    Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
    Bisogno G; Jenney M; Bergeron C; Gallego Melcón S; Ferrari A; Oberlin O; Carli M; Stevens M; Kelsey A; De Paoli A; Gaze MN; Martelli H; Devalck C; Merks JH; Ben-Arush M; Glosli H; Chisholm J; Orbach D; Minard-Colin V; De Salvo GL;
    Lancet Oncol; 2018 Aug; 19(8):1061-1071. PubMed ID: 29941280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
    Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
    Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyosarcoma of the female genitourinary tract: Primary and relapsed disease in infants and older children. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Matle M; Vokuhl C; Hallmen E; von Kalle T; Münter M; Timmermann B; Bielack SS; Klingebiel T; Koscielniak E; Seitz G;
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28889. PubMed ID: 33438323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of oncological outcomes of combination chemotherapy as a monotherapy for a select patient subset with non-metastatic non-alveolar bladder/prostate rhabdomyosarcoma.
    Abdelhalim A; Atwa AM; Helmy TE; Dawaba ME; Elashry R; Hafez AT
    J Pediatr Urol; 2021 Aug; 17(4):535.e1-535.e8. PubMed ID: 34092511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
    Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG).
    Rogers TN; De Corti F; Burrieza GG; Guérin F; Terwisscha van Scheltinga S; Smeulders N; Craigie R; Jenney M; Kelsey A; Zanetti I; Coppadoro B; De Salvo GL; Bisogno G; Martelli H
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28479. PubMed ID: 32573979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.
    Malempati S; Rodeberg DA; Donaldson SS; Lyden ER; Anderson JR; Hawkins DS; Arndt CA
    Cancer; 2011 Aug; 117(15):3493-501. PubMed ID: 21264837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
    Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
    Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
    Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E
    J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Hawkins DS; Chi YY; Anderson JR; Tian J; Arndt CAS; Bomgaars L; Donaldson SS; Hayes-Jordan A; Mascarenhas L; McCarville MB; McCune JS; McCowage G; Million L; Morris CD; Parham DM; Rodeberg DA; Rudzinski ER; Shnorhavorian M; Spunt SL; Skapek SX; Teot LA; Wolden S; Yock TI; Meyer WH
    J Clin Oncol; 2018 Sep; 36(27):2770-2777. PubMed ID: 30091945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.